Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,434,587
-$13,612,813 QoQ
Shares Held
100,148
-62.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#655
of 4,676 holders
Holding Since
Dec 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$25,397,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $38,832,049 across 4 Drug Manufacturers - General names. JNJ ranks #1 (65.5% of the industry book) .
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,434,587 | 100,148 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $25,397,000 | 100,000 | Put | Sole | 2026-08-14 | |
| 2024-12-31 | $39,047,400 | 270,000 | Shares | Sole | 2025-02-25 | |
| 2021-12-31 | $215,890 | 1,262 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||